aluates Reports

$ 0.0

Automative

Global Gene Therapy Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-14W13573

Global Gene Therapy Drugs Market Research Report 2023

BUY CHAPTERS

Global Gene Therapy Drugs Market Research Report 2025

Code: QYRE-Auto-14W13573

Report

July 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

F. Hoffmann-La Roche AG

Novartis International AG

Gilead Sciences Inc

Ultragenyx Pharmaceutical Inc

Applied Genetic Technologies Corp

Audentes Therapeutics

BioMarin Pharmaceutical

Bluebird bio

Nightstar Therapeutics

Sangamo Therapeutics

Spark Therapeutics

Uniqure

VBL Therapeutics

Voyager Therapeutics

Gene Therapy Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gene Therapy Drugs Market

The global market for Gene Therapy Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gene Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy Drugs.

The Gene Therapy Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Therapy Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Therapy Drugs Market Report

Report Metric	Details
Report Name	Gene Therapy Drugs Market
CAGR	5%
Segment by Type	Neuromuscular Disease Genetic Disease Other
Segment by Application	Hospital Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., Ultragenyx Pharmaceutical，Inc., Applied Genetic Technologies Corp, Audentes Therapeutics, BioMarin Pharmaceutical, Bluebird Bio, Nightstar Therapeutics, Sangamo Therapeutics, Spark Therapeutics, uniQure, VBL Therapeutics, Voyager Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Therapy Drugs Market report?

Ans: The main players in the Gene Therapy Drugs Market are F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., Ultragenyx Pharmaceutical，Inc., Applied Genetic Technologies Corp, Audentes Therapeutics, BioMarin Pharmaceutical, Bluebird Bio, Nightstar Therapeutics, Sangamo Therapeutics, Spark Therapeutics, uniQure, VBL Therapeutics, Voyager Therapeutics

What are the Application segmentation covered in the Gene Therapy Drugs Market report?

Ans: The Applications covered in the Gene Therapy Drugs Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Gene Therapy Drugs Market report?

Ans: The Types covered in the Gene Therapy Drugs Market report are Neuromuscular Disease, Genetic Disease, Other

Recommended Reports

Gene Therapy & Delivery

Genomics & Molecular Drugs

RNA & Targeted Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapy Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Neuromuscular Disease

1.2.3 Genetic Disease

1.2.4 Other

1.3 Market by Application

1.3.1 Global Gene Therapy Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Therapy Drugs Market Perspective (2020-2031)

2.2 Global Gene Therapy Drugs Growth Trends by Region

2.2.1 Global Gene Therapy Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gene Therapy Drugs Historic Market Size by Region (2020-2025)

2.2.3 Gene Therapy Drugs Forecasted Market Size by Region (2026-2031)

2.3 Gene Therapy Drugs Market Dynamics

2.3.1 Gene Therapy Drugs Industry Trends

2.3.2 Gene Therapy Drugs Market Drivers

2.3.3 Gene Therapy Drugs Market Challenges

2.3.4 Gene Therapy Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Therapy Drugs Players by Revenue

3.1.1 Global Top Gene Therapy Drugs Players by Revenue (2020-2025)

3.1.2 Global Gene Therapy Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gene Therapy Drugs Revenue

3.4 Global Gene Therapy Drugs Market Concentration Ratio

3.4.1 Global Gene Therapy Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Drugs Revenue in 2024

3.5 Global Key Players of Gene Therapy Drugs Head office and Area Served

3.6 Global Key Players of Gene Therapy Drugs, Product and Application

3.7 Global Key Players of Gene Therapy Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy Drugs Breakdown Data by Type

4.1 Global Gene Therapy Drugs Historic Market Size by Type (2020-2025)

4.2 Global Gene Therapy Drugs Forecasted Market Size by Type (2026-2031)

5 Gene Therapy Drugs Breakdown Data by Application

5.1 Global Gene Therapy Drugs Historic Market Size by Application (2020-2025)

5.2 Global Gene Therapy Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gene Therapy Drugs Market Size (2020-2031)

6.2 North America Gene Therapy Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gene Therapy Drugs Market Size by Country (2020-2025)

6.4 North America Gene Therapy Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Therapy Drugs Market Size (2020-2031)

7.2 Europe Gene Therapy Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gene Therapy Drugs Market Size by Country (2020-2025)

7.4 Europe Gene Therapy Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Therapy Drugs Market Size (2020-2031)

8.2 Asia-Pacific Gene Therapy Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gene Therapy Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Gene Therapy Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Therapy Drugs Market Size (2020-2031)

9.2 Latin America Gene Therapy Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gene Therapy Drugs Market Size by Country (2020-2025)

9.4 Latin America Gene Therapy Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Therapy Drugs Market Size (2020-2031)

10.2 Middle East & Africa Gene Therapy Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gene Therapy Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Gene Therapy Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 F. Hoffmann-La Roche AG

11.1.1 F. Hoffmann-La Roche AG Company Details

11.1.2 F. Hoffmann-La Roche AG Business Overview

11.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Introduction

11.1.4 F. Hoffmann-La Roche AG Revenue in Gene Therapy Drugs Business (2020-2025)

11.1.5 F. Hoffmann-La Roche AG Recent Development

11.2 Novartis International AG

11.2.1 Novartis International AG Company Details

11.2.2 Novartis International AG Business Overview

11.2.3 Novartis International AG Gene Therapy Drugs Introduction

11.2.4 Novartis International AG Revenue in Gene Therapy Drugs Business (2020-2025)

11.2.5 Novartis International AG Recent Development

11.3 Gilead Sciences, Inc.

11.3.1 Gilead Sciences, Inc. Company Details

11.3.2 Gilead Sciences, Inc. Business Overview

11.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Introduction

11.3.4 Gilead Sciences, Inc. Revenue in Gene Therapy Drugs Business (2020-2025)

11.3.5 Gilead Sciences, Inc. Recent Development

11.4 Ultragenyx Pharmaceutical，Inc.

11.4.1 Ultragenyx Pharmaceutical，Inc. Company Details

11.4.2 Ultragenyx Pharmaceutical，Inc. Business Overview

11.4.3 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Introduction

11.4.4 Ultragenyx Pharmaceutical，Inc. Revenue in Gene Therapy Drugs Business (2020-2025)

11.4.5 Ultragenyx Pharmaceutical，Inc. Recent Development

11.5 Applied Genetic Technologies Corp

11.5.1 Applied Genetic Technologies Corp Company Details

11.5.2 Applied Genetic Technologies Corp Business Overview

11.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Introduction

11.5.4 Applied Genetic Technologies Corp Revenue in Gene Therapy Drugs Business (2020-2025)

11.5.5 Applied Genetic Technologies Corp Recent Development

11.6 Audentes Therapeutics

11.6.1 Audentes Therapeutics Company Details

11.6.2 Audentes Therapeutics Business Overview

11.6.3 Audentes Therapeutics Gene Therapy Drugs Introduction

11.6.4 Audentes Therapeutics Revenue in Gene Therapy Drugs Business (2020-2025)

11.6.5 Audentes Therapeutics Recent Development

11.7 BioMarin Pharmaceutical

11.7.1 BioMarin Pharmaceutical Company Details

11.7.2 BioMarin Pharmaceutical Business Overview

11.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Introduction

11.7.4 BioMarin Pharmaceutical Revenue in Gene Therapy Drugs Business (2020-2025)

11.7.5 BioMarin Pharmaceutical Recent Development

11.8 Bluebird Bio

11.8.1 Bluebird Bio Company Details

11.8.2 Bluebird Bio Business Overview

11.8.3 Bluebird Bio Gene Therapy Drugs Introduction

11.8.4 Bluebird Bio Revenue in Gene Therapy Drugs Business (2020-2025)

11.8.5 Bluebird Bio Recent Development

11.9 Nightstar Therapeutics

11.9.1 Nightstar Therapeutics Company Details

11.9.2 Nightstar Therapeutics Business Overview

11.9.3 Nightstar Therapeutics Gene Therapy Drugs Introduction

11.9.4 Nightstar Therapeutics Revenue in Gene Therapy Drugs Business (2020-2025)

11.9.5 Nightstar Therapeutics Recent Development

11.10 Sangamo Therapeutics

11.10.1 Sangamo Therapeutics Company Details

11.10.2 Sangamo Therapeutics Business Overview

11.10.3 Sangamo Therapeutics Gene Therapy Drugs Introduction

11.10.4 Sangamo Therapeutics Revenue in Gene Therapy Drugs Business (2020-2025)

11.10.5 Sangamo Therapeutics Recent Development

11.11 Spark Therapeutics

11.11.1 Spark Therapeutics Company Details

11.11.2 Spark Therapeutics Business Overview

11.11.3 Spark Therapeutics Gene Therapy Drugs Introduction

11.11.4 Spark Therapeutics Revenue in Gene Therapy Drugs Business (2020-2025)

11.11.5 Spark Therapeutics Recent Development

11.12 uniQure

11.12.1 uniQure Company Details

11.12.2 uniQure Business Overview

11.12.3 uniQure Gene Therapy Drugs Introduction

11.12.4 uniQure Revenue in Gene Therapy Drugs Business (2020-2025)

11.12.5 uniQure Recent Development

11.13 VBL Therapeutics

11.13.1 VBL Therapeutics Company Details

11.13.2 VBL Therapeutics Business Overview

11.13.3 VBL Therapeutics Gene Therapy Drugs Introduction

11.13.4 VBL Therapeutics Revenue in Gene Therapy Drugs Business (2020-2025)

11.13.5 VBL Therapeutics Recent Development

11.14 Voyager Therapeutics

11.14.1 Voyager Therapeutics Company Details

11.14.2 Voyager Therapeutics Business Overview

11.14.3 Voyager Therapeutics Gene Therapy Drugs Introduction

11.14.4 Voyager Therapeutics Revenue in Gene Therapy Drugs Business (2020-2025)

11.14.5 Voyager Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

F. Hoffmann-La Roche AG

Novartis International AG

Gilead Sciences Inc

Ultragenyx Pharmaceutical Inc

Applied Genetic Technologies Corp

Audentes Therapeutics

BioMarin Pharmaceutical

Bluebird bio

Nightstar Therapeutics

Sangamo Therapeutics

Spark Therapeutics

Uniqure

VBL Therapeutics

Voyager Therapeutics

List of Tables

Table 1. Global Gene Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Neuromuscular Disease

Table 3. Key Players of Genetic Disease

Table 4. Key Players of Other

Table 5. Global Gene Therapy Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Gene Therapy Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Gene Therapy Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Gene Therapy Drugs Market Share by Region (2020-2025)

Table 9. Global Gene Therapy Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Gene Therapy Drugs Market Share by Region (2026-2031)

Table 11. Gene Therapy Drugs Market Trends

Table 12. Gene Therapy Drugs Market Drivers

Table 13. Gene Therapy Drugs Market Challenges

Table 14. Gene Therapy Drugs Market Restraints

Table 15. Global Gene Therapy Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Gene Therapy Drugs Market Share by Players (2020-2025)

Table 17. Global Top Gene Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Drugs as of 2024)

Table 18. Ranking of Global Top Gene Therapy Drugs Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Gene Therapy Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Gene Therapy Drugs, Headquarters and Area Served

Table 21. Global Key Players of Gene Therapy Drugs, Product and Application

Table 22. Global Key Players of Gene Therapy Drugs, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Gene Therapy Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Gene Therapy Drugs Revenue Market Share by Type (2020-2025)

Table 26. Global Gene Therapy Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Gene Therapy Drugs Revenue Market Share by Type (2026-2031)

Table 28. Global Gene Therapy Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Gene Therapy Drugs Revenue Market Share by Application (2020-2025)

Table 30. Global Gene Therapy Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Gene Therapy Drugs Revenue Market Share by Application (2026-2031)

Table 32. North America Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Gene Therapy Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Gene Therapy Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Gene Therapy Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Gene Therapy Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Gene Therapy Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Gene Therapy Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Gene Therapy Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Gene Therapy Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Gene Therapy Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Gene Therapy Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Gene Therapy Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 47. F. Hoffmann-La Roche AG Company Details

Table 48. F. Hoffmann-La Roche AG Business Overview

Table 49. F. Hoffmann-La Roche AG Gene Therapy Drugs Product

Table 50. F. Hoffmann-La Roche AG Revenue in Gene Therapy Drugs Business (2020-2025) & (US$ Million)

Table 51. F. Hoffmann-La Roche AG Recent Development

Table 52. Novartis International AG Company Details

Table 53. Novartis International AG Business Overview

Table 54. Novartis International AG Gene Therapy Drugs Product

Table 55. Novartis International AG Revenue in Gene Therapy Drugs Business (2020-2025) & (US$ Million)

Table 56. Novartis International AG Recent Development

Table 57. Gilead Sciences, Inc. Company Details

Table 58. Gilead Sciences, Inc. Business Overview

Table 59. Gilead Sciences, Inc. Gene Therapy Drugs Product

Table 60. Gilead Sciences, Inc. Revenue in Gene Therapy Drugs Business (2020-2025) & (US$ Million)

Table 61. Gilead Sciences, Inc. Recent Development

Table 62. Ultragenyx Pharmaceutical，Inc. Company Details

Table 63. Ultragenyx Pharmaceutical，Inc. Business Overview

Table 64. Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Product

Table 65. Ultragenyx Pharmaceutical，Inc. Revenue in Gene Therapy Drugs Business (2020-2025) & (US$ Million)

Table 66. Ultragenyx Pharmaceutical，Inc. Recent Development

Table 67. Applied Genetic Technologies Corp Company Details

Table 68. Applied Genetic Technologies Corp Business Overview

Table 69. Applied Genetic Technologies Corp Gene Therapy Drugs Product

Table 70. Applied Genetic Technologies Corp Revenue in Gene Therapy Drugs Business (2020-2025) & (US$ Million)

Table 71. Applied Genetic Technologies Corp Recent Development

Table 72. Audentes Therapeutics Company Details

Table 73. Audentes Therapeutics Business Overview

Table 74. Audentes Therapeutics Gene Therapy Drugs Product

Table 75. Audentes Therapeutics Revenue in Gene Therapy Drugs Business (2020-2025) & (US$ Million)

Table 76. Audentes Therapeutics Recent Development

Table 77. BioMarin Pharmaceutical Company Details

Table 78. BioMarin Pharmaceutical Business Overview

Table 79. BioMarin Pharmaceutical Gene Therapy Drugs Product

Table 80. BioMarin Pharmaceutical Revenue in Gene Therapy Drugs Business (2020-2025) & (US$ Million)

Table 81. BioMarin Pharmaceutical Recent Development

Table 82. Bluebird Bio Company Details

Table 83. Bluebird Bio Business Overview

Table 84. Bluebird Bio Gene Therapy Drugs Product

Table 85. Bluebird Bio Revenue in Gene Therapy Drugs Business (2020-2025) & (US$ Million)

Table 86. Bluebird Bio Recent Development

Table 87. Nightstar Therapeutics Company Details

Table 88. Nightstar Therapeutics Business Overview

Table 89. Nightstar Therapeutics Gene Therapy Drugs Product

Table 90. Nightstar Therapeutics Revenue in Gene Therapy Drugs Business (2020-2025) & (US$ Million)

Table 91. Nightstar Therapeutics Recent Development

Table 92. Sangamo Therapeutics Company Details

Table 93. Sangamo Therapeutics Business Overview

Table 94. Sangamo Therapeutics Gene Therapy Drugs Product

Table 95. Sangamo Therapeutics Revenue in Gene Therapy Drugs Business (2020-2025) & (US$ Million)

Table 96. Sangamo Therapeutics Recent Development

Table 97. Spark Therapeutics Company Details

Table 98. Spark Therapeutics Business Overview

Table 99. Spark Therapeutics Gene Therapy Drugs Product

Table 100. Spark Therapeutics Revenue in Gene Therapy Drugs Business (2020-2025) & (US$ Million)

Table 101. Spark Therapeutics Recent Development

Table 102. uniQure Company Details

Table 103. uniQure Business Overview

Table 104. uniQure Gene Therapy Drugs Product

Table 105. uniQure Revenue in Gene Therapy Drugs Business (2020-2025) & (US$ Million)

Table 106. uniQure Recent Development

Table 107. VBL Therapeutics Company Details

Table 108. VBL Therapeutics Business Overview

Table 109. VBL Therapeutics Gene Therapy Drugs Product

Table 110. VBL Therapeutics Revenue in Gene Therapy Drugs Business (2020-2025) & (US$ Million)

Table 111. VBL Therapeutics Recent Development

Table 112. Voyager Therapeutics Company Details

Table 113. Voyager Therapeutics Business Overview

Table 114. Voyager Therapeutics Gene Therapy Drugs Product

Table 115. Voyager Therapeutics Revenue in Gene Therapy Drugs Business (2020-2025) & (US$ Million)

Table 116. Voyager Therapeutics Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Gene Therapy Drugs Picture

Figure 2. Global Gene Therapy Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gene Therapy Drugs Market Share by Type: 2024 VS 2031

Figure 4. Neuromuscular Disease Features

Figure 5. Genetic Disease Features

Figure 6. Other Features

Figure 7. Global Gene Therapy Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Gene Therapy Drugs Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Pharmacy Case Studies

Figure 11. Gene Therapy Drugs Report Years Considered

Figure 12. Global Gene Therapy Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Gene Therapy Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Gene Therapy Drugs Market Share by Region: 2024 VS 2031

Figure 15. Global Gene Therapy Drugs Market Share by Players in 2024

Figure 16. Global Top Gene Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Drugs as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy Drugs Revenue in 2024

Figure 18. North America Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Gene Therapy Drugs Market Share by Country (2020-2031)

Figure 20. United States Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Gene Therapy Drugs Market Share by Country (2020-2031)

Figure 24. Germany Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Gene Therapy Drugs Market Share by Region (2020-2031)

Figure 32. China Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Gene Therapy Drugs Market Share by Country (2020-2031)

Figure 40. Mexico Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Gene Therapy Drugs Market Share by Country (2020-2031)

Figure 44. Turkey Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Gene Therapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. F. Hoffmann-La Roche AG Revenue Growth Rate in Gene Therapy Drugs Business (2020-2025)

Figure 48. Novartis International AG Revenue Growth Rate in Gene Therapy Drugs Business (2020-2025)

Figure 49. Gilead Sciences, Inc. Revenue Growth Rate in Gene Therapy Drugs Business (2020-2025)

Figure 50. Ultragenyx Pharmaceutical，Inc. Revenue Growth Rate in Gene Therapy Drugs Business (2020-2025)

Figure 51. Applied Genetic Technologies Corp Revenue Growth Rate in Gene Therapy Drugs Business (2020-2025)

Figure 52. Audentes Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2020-2025)

Figure 53. BioMarin Pharmaceutical Revenue Growth Rate in Gene Therapy Drugs Business (2020-2025)

Figure 54. Bluebird Bio Revenue Growth Rate in Gene Therapy Drugs Business (2020-2025)

Figure 55. Nightstar Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2020-2025)

Figure 56. Sangamo Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2020-2025)

Figure 57. Spark Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2020-2025)

Figure 58. uniQure Revenue Growth Rate in Gene Therapy Drugs Business (2020-2025)

Figure 59. VBL Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2020-2025)

Figure 60. Voyager Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cellular and Gene Therapy Product Market Research Report 2025

Gene Therapy Medicinal Products GTMP Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lentiviral Vector In Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cell and Gene Therapy Tools and Reagents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cell and Gene Therapy Bioassay Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Osteoarthritis Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RNA Based Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmacogenomics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cell and Gene Therapy Manufacturing QC Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Genome Based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Genetically Engineered Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non invasive Prenatal Genetic Testing Market Research Report 2025

Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Predictive Genetic Testing and Genomics Market Research Report 2025

Autism Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CRISPR Gene Testing and Diagnostics Market Research Report 2024

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions